Swedish precision motion technology company Acuvi AB saw its shares fall 15.72% to $9.49 in early trading on Thursday after the firm issued a profit warning for the second quarter of 2026 and reduced its full-year guidance.
The company, which operates through subsidiaries including PiezoMotor and Sensapex, reported a SEK 9 million operating loss in Q2 2026, compared with a profit in the same period a year earlier. Net sales rose 6% year-over-year to SEK 50 million, while operating cash flow turned negative at SEK 9.5 million. Acuvi ended the quarter with SEK 19.8 million in cash.
Gross margins declined to 51% in Q2 2026 from 65% in the prior-year quarter, though management noted the full-year 2025 margin of 55% as a more relevant comparison. The company also set a target to reduce costs by more than 10% for the full year.
Acuvi cited the loss of a major U.S. distribution agreement, which previously generated about SEK 50 million annually, as a key factor in its reduced outlook. The firm now expects the deal’s absence to reduce revenue by SEK 20 million in 2026 and SEK 30 million in 2027.
Despite the challenges, PiezoMotor’s first-half sales surged 100% year-over-year, driven by semiconductor and space sector orders, and the company maintained a full-year growth target of at least 50%. Management also stated it does not anticipate a near-term capital raise outside of potential acquisitions.
Acuvi’s stock has declined 34.76% year-to-date, trading just above its 52-week low of $9.17 and well below its 52-week high of $30.65.
